Day: January 5, 2026

Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates

The Company enters 2026 with Multiple Phase 2 Catalysts collectively representing ~$8 billion in potential market opportunities, an AI-enabled development...

RELIEF AI’s Digital Well-Being Innovation “RELIEF AI – Naia” Recognized as a “Recommended Measure for 2025” by Leading German Health Promotion Organization

error: Content is protected !!